I Daizadeh - Iberoamerican Journal of Science Measurement and …, 2021 - eprints.rclis.org
Objective. This paper seeks to test the existence of a “long-run” equilibrium (LRE) dynamic between trademarks and patents, as it would suggest that similar exogenous pressures …
S Wittayanukorn, M Rosenberg, A Schick, M Hu… - … Innovation & Regulatory …, 2020 - Springer
Background Increasing generic drug price competition by facilitating abbreviated new drug applications (ANDA) submission may help patients have access to affordable care. This …
I Daizadeh - Pharmaceutical Research, 2023 - Springer
Purpose Is the complexity of medical product (medicines and medical devices) regulation impacting innovation in the US? If so, how? Methods Here, this question is investigated as …
Abstract The US Food and Drug Administration (FDA) regulates medical devices (MD), which are predicated on a concoction of economic and policy forces (eg, supply/demand …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-19; HCoV-19; COVID-19) has affected all daily activities. Has it also affected the number of United States (FDA) drug …
An Food and Drug Administration (FDA; Agency) guideline (which may include Guidance Document, Compliance Policy Guide (CPG), Small Entity Compliance Guide, Information …
It is challenging to elucidate the effects of changes in external influences (such as economic or policy) on the rate of US drug approvals. Here, a novel approach—termed the …
I Daizadeh - arXiv preprint arXiv:2012.10400, 2020 - arxiv.org
Through time series analysis, this paper empirically explores, confirms and extends the trademark/patent inter-relationship as proposed in the normative intellectual-property (IP) …
In the United States (US), the Food and Drug Administration (FDA) regulates medical devices (MDs). Though not a fair comparison but for illustrative purposes: a majority of …